Sorry, you need to enable JavaScript to visit this website.

The Advanced Photon Source
a U.S. Department of Energy Office of Science User Facility

Another discovery by users of the Advanced Photon Source

Probing the Structure of a Promising NASICON Material:  Research carried out at the U.S. Department of Energy’s Advanced Photon Source provides fresh insights into the process of homogeneous nucleation and identifying superstructural units in glass ― a necessary step in engineering effective solid-state electrolytes with enhanced ionic conductivity. 

A Riddle Solved by Research at the Advanced Photon Source

Probing Thin-Film Superconductivity at the Picoscale:  Researchers in this study employed the U.S. Department of Energy’s Advanced Photon Source to obtain new data that are expected to aid in understanding the exact mechanisms responsible for thin-film superconductivity, which is essential for applying these materials to practical high-temperature superconducting devices and developing better performing superconductors.

Another discovery by users of the Advanced Photon Source

A Crystal-Clear Way to Save Time:  Researchers collaboratively used the U.S. Department of Energy’s Advanced Photon Source in their discovery of a better way to make a new class of soft materials—reducing a process that used to take five months down to three minutes.

Advanced Photon Source Research with Positive Impacts on Our Health

Capturing How DNA-Repair Enzymes Bridge the Gaps:  It is well known that DNA is critical to life itself, playing a role in almost everything we do and impacting our health as well as disease. Research at the U.S. Department of Energy’s Advanced Photon Source is providing insights about DNA repair that will enhance our understanding of cancer and other diseases in which DNA breaks may play a role.

Advanced Photon Source Research with Positive Impacts on Our Health

Making Better Drugs by Controlling Membrane Mechanics:  Cellular membranes are the body's wall of defense against invaders, with the tricky task of blocking the bad guys while letting beneficial molecules come and go. Measurements obtained at the U.S. Department of Energy’s Advanced Photon Source paint a detailed picture of how a potential membrane-targeting treatment protects cells from pathogens, providing insights that could bolster the next generation of pharmaceutical defenses.

Advanced Photon Source Research with Positive Impacts on Our Health

Existing Drug is Shown to Inhibit SARS-Cov-2 Virus:  A new University of Chicago study based on research at the U.S. Department of Energy’s Advanced Photon Source has found that the drug masitinib may be effective in treating COVID-19.

A technology breakthrough at the Advanced Photon Source

A Cold-Spray Solution for AM Metal Fatigue:  This work, carried out at the U.S. Department of Energy’s Advanced Photon Source, shows that the integration of additive manufacturing with the cold spray coating process can offer an intriguing way to overcome limitations and further increase the versatility of additive manufacturing techniques. 

Advanced Photon Source Research with Positive Impacts on Our Health

Deconstructing the Infectious Machinery of SARS-CoV-2:  Scientists from three U.S. Department of Energy national laboratories have published research at those DOE laboratories that – alongside other recent, complementary studies of coronavirus proteins and genetics – represents the first step toward developing treatments for COVID-19.

Advanced Photon Source Research with Positive Impacts on Our Health

Solving the Structure of BRCA2 Protein Complex Important in DNA Repair:  The initials BRCA2 may be best known for a gene associated with many cases of breast cancer, and the protein encoded by the BRCA2 gene is critical to repairing breaks in DNA. Researchers used the U.S. Department of Energy’s Advanced Photon Source to determine the structure of a complex of two proteins that allows repairs to happen efficiently in cells undergoing cell-splitting, called meiosis. Their results have major implications for cancer and infertility.

Another discovery by users of the Advanced Photon Source

Sniffing Out a Better Covalent Organic Framework:  Research on covalent organic frameworks at the U.S. Department of Energy's Advanced Photon Source will open the way to effective manufacturing techniques to make them commercially viable materials.

Advanced Photon Source Research with Positive Impacts on Our Health

Mouse Brain Imaged from the Microscopic to the Macroscopic Level:  Researchers at the University of Chicago and the U.S. Department of Energy’s National Laboratory imaged an entire mouse brain across five orders of magnitude of resolution, allowing scientists to better connect existing imaging approaches and uncover new details about the structure of the brain.

FROM THE APS DIRECTOR
September 16, 2021

NEW ARGONNE SITE ACCESS REQUIREMENTS TAKE EFFECT SEPTEMBER 20, 2021

Argonne continues to implement necessary safety measures to protect our employees and users from the negative impacts of COVID-19 on our personal health and on our scientific mission.

Following White House Executive Orders and the full FDA approval for the Pfizer vaccine, Argonne adopted a new policy that requires all laboratory employees to verify that they are fully vaccinated against COVID-19, and put in place new protocols for users and visitors to access laboratory sites.   

Argonne and the Advanced Photon Source (APS) remain in limited operations. The number of general users allowed on site also remains capped on a per-experiment basis.

The only general users allowed onsite at the APS are:

  • Those identified as onsite users on approved ESAFs; or
  • Those approved for site access by gate pass.

Starting September 20, 2021, all general users and visitors to Argonne facilities, who are not Argonne employees or Collaborative Access Team (CAT) operations staff, will be required to report to the Argonne Information Center (AIC).

Before site access will be granted, general users and visitors must:

  • attest to their vaccination status (form will be provided at the AIC)
  • if not fully vaccinated, show proof of a negative COVID-19 test result that is less than 72 hours old.

For more details about site access, visit the APS User Info webpage.

Seminars, Training, Schools, Etc

-

1:30 p.m. Virtual

1:00 p.m. Virtual